Stock analysts at StockNews.com initiated coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a research note issued on Friday. The brokerage set a “hold” rating on the medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback